Pre-clinical evaluation of small molecule LOXL2 inhibitors in breast cancer
Joan Chang(University of Copenhagen), Thomas R. Cox(Garvan Institute of Medical Research)
Cited by 107
Related Papers
Tumor Biomechanics Alters Metastatic Dissemination of Triple Negative Breast Cancer via Rewiring Fatty Acid Metabolism
|Advanced Science|2024|23
The importance of developing therapies targeting the biological spectrum of metastatic disease
|Clinical & Experimental Metastasis|2019|13